Case 35 Breast Augmentation

Zachary Okhah and Richard Zienowicz

Case 35 Breast Augmentation

Case 35 (a, b) A 21-year-old female presents to your office to discuss breast augmentation.

35.1 Description

  • Hypomastia: Small A cup breasts with mild asymmetry

  • Right inframammary fold is slightly higher than the left side

  • Right nipple is slightly higher than the left nipple

35.2 Work-Up

35.2.1 History

  • Age, medical comorbidities, anticoagulant use, and smoking history

  • Pregnancy/breastfeeding history; plans for future childbearing

  • Personal history of breast disease and/or procedures, prior mammography or ultrasound

  • Family history of breast cancer

  • Current bra size and desired breast size

  • Motivation for surgery

35.2.2 Physical Examination

  • Evaluate breast shape, skin quality, and adequacy of tissue envelope (e.g., upper pole pinch thickness)

  • Identify any asymmetries (volume, nipple–areola complex, inframammary fold position) and thoracic wall abnormalities

  • Palpate for breast masses or axillary lymphadenopathy; identify skin dimpling or nipple discharge

35.2.3 Diagnostic Studies

  • American Cancer Society guidelines for clinical breast exam (CBE) and mammography should be followed

    • Clinical breast examination every 3 years for women aged 20 to 39 years

    • Breast examination annually for women aged 40 and older

    • Yearly mammograms for women aged 40 and older

  • Breast masses or lymphadenopathy discovered on physical examination should be evaluated before augmentation

35.3 Patient Counseling

  • An effective consultation establishes an accurate understanding of the patient’s goals from the surgeon’s perspective, and establishes realistic expectations of the final result from the patient’s perspective.

  • Informed consent must include management of patient expectations and thorough discussion of existing asymmetries, potential complications, rupture screening recommendations, rates of revisional surgery (approximately 20%), responsibility for cost of revisions, and eventual need for implant exchange or removal

  • Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

    • All patients being evaluated for breast implants should be informed of the risks and common presentations of BIA-ALCL.

    • Clinical experience has shown that this process is generally well received and is not disruptive to patient interactions.

    • When counseling on implant options, patients should be informed that BIA-ALCL is a predominantly textured implant-associated disease, although it is premature to conclude at this point that it cannot occur in smooth implants.

    • Both silicone (57%) and saline (43%) implants have been linked to BIA-ALCL with no specific predilection.

Only gold members can continue reading. Log In or Register to continue

Jul 17, 2021 | Posted by in General Surgery | Comments Off on Case 35 Breast Augmentation
Premium Wordpress Themes by UFO Themes